Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+/S252W) mouse
- PMID: 15975938
- DOI: 10.1242/dev.01914
Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+/S252W) mouse
Abstract
Apert syndrome is an autosomal dominant disorder characterized by malformations of the skull, limbs and viscera. Two-thirds of affected individuals have a S252W mutation in fibroblast growth factor receptor 2 (FGFR2). To study the pathogenesis of this condition, we generated a knock-in mouse model with this mutation. The Fgfr2(+/S252W) mutant mice have abnormalities of the skeleton, as well as of other organs including the brain, thymus, lungs, heart and intestines. In the mutant neurocranium, we found a midline sutural defect and craniosynostosis with abnormal osteoblastic proliferation and differentiation. We noted ectopic cartilage at the midline sagittal suture, and cartilage abnormalities in the basicranium, nasal turbinates and trachea. In addition, from the mutant long bones, in vitro cell cultures grown in osteogenic medium revealed chondrocytes, which were absent in the controls. Our results suggest that altered cartilage and bone development play a significant role in the pathogenesis of the Apert syndrome phenotype.
Similar articles
-
A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis.Bone. 2008 Apr;42(4):631-43. doi: 10.1016/j.bone.2007.11.019. Epub 2008 Jan 31. Bone. 2008. PMID: 18242159
-
A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome.J Biol Chem. 2004 Oct 29;279(44):45926-34. doi: 10.1074/jbc.M404824200. Epub 2004 Aug 13. J Biol Chem. 2004. PMID: 15310757
-
Soluble form of FGFR2 with S252W partially prevents craniosynostosis of the apert mouse model.Dev Dyn. 2014 Apr;243(4):560-7. doi: 10.1002/dvdy.24099. Epub 2013 Dec 19. Dev Dyn. 2014. PMID: 24259495
-
[From gene to disease; craniosynostosis syndromes due to FGFR2-mutation].Ned Tijdschr Geneeskd. 2002 Jan 12;146(2):63-6. Ned Tijdschr Geneeskd. 2002. PMID: 11820058 Review. Dutch.
-
FGFs, their receptors, and human limb malformations: clinical and molecular correlations.Am J Med Genet. 2002 Oct 15;112(3):266-78. doi: 10.1002/ajmg.10775. Am J Med Genet. 2002. PMID: 12357470 Review.
Cited by
-
Brain phenotypes in two FGFR2 mouse models for Apert syndrome.Dev Dyn. 2010 Mar;239(3):987-97. doi: 10.1002/dvdy.22218. Dev Dyn. 2010. PMID: 20077479 Free PMC article.
-
Excessive osteoclast activation by osteoblast paracrine factor RANKL is a major cause of the abnormal long bone phenotype in Apert syndrome model mice.J Cell Physiol. 2022 Apr;237(4):2155-2168. doi: 10.1002/jcp.30682. Epub 2022 Jan 20. J Cell Physiol. 2022. PMID: 35048384 Free PMC article.
-
FGF/FGFR signaling coordinates skull development by modulating magnitude of morphological integration: evidence from Apert syndrome mouse models.PLoS One. 2011;6(10):e26425. doi: 10.1371/journal.pone.0026425. Epub 2011 Oct 28. PLoS One. 2011. PMID: 22053191 Free PMC article.
-
Morphological comparison of the craniofacial phenotypes of mouse models expressing the Apert FGFR2 S252W mutation in neural crest- or mesoderm-derived tissues.Bone. 2014 Jun;63:101-9. doi: 10.1016/j.bone.2014.03.003. Epub 2014 Mar 13. Bone. 2014. PMID: 24632501 Free PMC article.
-
Signaling networks in joint development.Dev Dyn. 2017 Apr;246(4):262-274. doi: 10.1002/dvdy.24472. Epub 2016 Dec 29. Dev Dyn. 2017. PMID: 27859991 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous
